Food and Microbiome Longitudinal Investigation (FAMiLI)

Recruiting

• Conditions: Cancer; Cardiovascular Diseases

• Registration Number: NCT03293758
• Lead Sponsor: NYU Langone Health

Brief Summary

The NYU Human Microbiome Study Cohort is designed to improve understanding of the role of human microbiome in health and disease. This study will serve as a critical NYU biorepository resource for research on human genetics and the microbiome in health and disease

Detailed Description

Not available

Study Timeline

• Study Start: 2016-05-16
• Study First Submitted: 2017-09-22
• Study First Submitted QC: 2017-09-22
• Study First Posted: 2017-09-26
• Status Verified: 2023-10
• Last Update Submitted: 2023-10-24
• Last Update Posted: 2023-10-25
• Primary Completion: 2024-12-31
• Study Completion: 2034-12-31

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 14000

Inclusion Criteria

• Age > 40

Read More

Exclusion Criteria

• Use of long term antibiotics.
• Pregnant

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Demographic	5 Years	sex, race, education, oral health status, lifestyle, medical history, anthropometry, and medication use will be collected using the baseline questionnaire at enrolment. The collected information will provide risk stratification information for statistical control in studies of colorectal tumors and other major chronic diseases.

Secondary Outcome Measures

Name	Time	Method
Differences in human microbiota between subjects with colorectal adenoma or colorectal cancer and those without.	5 Years	Pairwise alignment and clustering of sequences into operational taxonomic units (OTUs)

Trial Locations

Locations (1)

New York University School of Medicine; 🇺🇸 New York, New York, United States